Company emerges from stealth with $80M in funding to transform fragmented brain healthcare system through next-generation clinics, offering access to rapid-acting personalized treatment
Salma Health has officially launched its advanced Brain Health Center of Excellence, marking a transformative step in how neurological and psychiatric conditions are diagnosed, treated, and managed across the United States. Backed by $80 million in Series A funding co-led by Mubadala Capital and ARCH Venture Partners, the company is building a next-generation, integrated healthcare model that combines advanced diagnostics, rapid-acting therapeutics, AI in healthcare, and continuous patient care coordination under one roof.
Health Technology Insights: https://healthtechnologyinsights.com/how-health-technology-is-strengthening-global-healthcare-access/
Designed to address the growing brain health crisis, Salma Health’s model integrates in-person medical services, telehealth, clinical research, and an AI-driven technology platform to create a unified care pathway for patients. More than one-third of Americans experience a brain health condition each year, yet traditional healthcare systems remain fragmented. Patients often navigate psychiatry, neurology, psychology, and crisis care separately, leading to delayed diagnoses and inconsistent treatment outcomes.
Salma Health directly confronts this challenge through three core pillars. First, specially equipped clinics provide comprehensive psychiatric and neurological services across all acuity levels. These centers deliver advanced therapeutics, including transcranial magnetic stimulation (TMS), SAINT® neuromodulation protocols, esketamine therapy, psychotherapy, and pharmacotherapy. Each treatment plan is personalized through rigorous medical evaluation, supported by digital tools and AI-powered decision support systems to enhance patient outcomes.
Health Technology Insights: https://healthtechnologyinsights.com/westfax-launches-ai-document-platform-for-healthcare/
Second, Salma Health integrates clinical research capabilities to conduct FDA-regulated trials in collaboration with pharmaceutical and medical device companies. This allows patients to access innovative therapies while contributing to the advancement of medical science and evidence-based brain healthcare.
Third, the company is developing Brain Health OS, a proprietary AI-driven platform designed to unify clinical data, operational coordination, and generative AI capabilities. By analyzing demographic, neural, physiological, and digital markers, the platform enables predictive care models, early relapse detection, and precision treatment matching. This AI in healthcare infrastructure aims to move beyond trial-and-error approaches toward personalized, data-driven brain care.
Health Technology Insights: https://healthtechnologyinsights.com/revspring-acquires-trustcommerce-to-expand-healthcare-payments/
With locations now open in San Diego, Orange County, Fremont, and Berkeley – further expansion planned nationwide – Salma Health is positioning itself as a leader in integrated medical innovation. By combining advanced therapeutics, research partnerships, and AI-enabled patient engagement, the company seeks to redefine standards in psychiatric and neurological care while generating measurable clinical outcomes.
As healthcare organizations accelerate adoption of AI in healthcare and precision medicine, Salma Health’s launch signals a new era of coordinated, technology-enabled brain health delivery focused on long-term patient recovery and system-wide transformation.
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
